Ignite Creation Date:
2024-05-05 @ 11:53 AM
Last Modification Date:
2024-10-26 @ 9:15 AM
Study NCT ID:
NCT00166842
Status:
UNKNOWN
Last Update Posted:
2005-09-14
First Post:
2005-09-12
Brief Title:
Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
Effects of Conversion From Sirolimus Oral Solution to Tablets in Renal Transplant Recipients
Status:
UNKNOWN
Status Verified Date:
2002-07
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to understand the pharmacokinetics of sirolimus tablets in different regimens in newly renal transplant patients and the effect of dosage form conversion on the concentration of sirolimus in stable renal transplant patients So that we can design a better tacrolimus or cyclosporinesirolimussteroid dose regimen for Taiwanese
Detailed Description:
Sirolimus tablets will be available more than one year after the launch of sirolimus solution Most patients on sirolimus solution will use sirolimus tablet instead
The purpose of this study is to understand the pharmacokinetics of sirolimus tablets in different regimens in newly renal transplant patients and the effect of dosage form conversion on the concentration of sirolimus in stable renal transplant patients So that we can design a better tacrolimus or cyclosporinesirolimussteroid dose regimen for Taiwanese
The purpose of this study is to understand the pharmacokinetics of sirolimus tablets in different regimens in newly renal transplant patients and the effect of dosage form conversion on the concentration of sirolimus in stable renal transplant patients So that we can design a better tacrolimus or cyclosporinesirolimussteroid dose regimen for Taiwanese
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NTUH S92 | None | None | None |